>
Switch to:

Indaptus Therapeutics Cash-to-Debt

: 26.97 (As of Jun. 2021)
View and export this data going back to 2021. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Indaptus Therapeutics's cash to debt ratio for the quarter that ended in Jun. 2021 was 26.97.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Indaptus Therapeutics could pay off its debt using the cash in hand for the quarter that ended in Jun. 2021.

The historical rank and industry rank for Indaptus Therapeutics's Cash-to-Debt or its related term are showing as below:

NAS:INDP' s Cash-to-Debt Range Over the Past 10 Years
Min: 26.97   Med: 5013.49   Max: No Debt
Current: 26.97

26.97
No Debt

During the past 0 years, Indaptus Therapeutics's highest Cash to Debt Ratio was No Debt. The lowest was 26.97. And the median was 5013.49.

NAS:INDP's Cash-to-Debt is ranked lower than
99.99% of the 319 Companies
in the Biotechnology industry.

( Industry Median: 10.28 vs. NAS:INDP: 26.97 )

Indaptus Therapeutics Cash-to-Debt Historical Data

The historical data trend for Indaptus Therapeutics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indaptus Therapeutics Annual Data
Trend
Cash-to-Debt

Indaptus Therapeutics Quarterly Data
Jun20 Mar21 Jun21
Cash-to-Debt N/A No Debt 26.97

Competitive Comparison

For the Biotechnology subindustry, Indaptus Therapeutics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Indaptus Therapeutics Cash-to-Debt Distribution

For the Biotechnology industry and Healthcare sector, Indaptus Therapeutics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Indaptus Therapeutics's Cash-to-Debt falls into.



Indaptus Therapeutics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Indaptus Therapeutics's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Indaptus Therapeutics's Cash to Debt Ratio for the quarter that ended in Jun. 2021 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indaptus Therapeutics  (NAS:INDP) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Indaptus Therapeutics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Indaptus Therapeutics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Indaptus Therapeutics Business Description

Indaptus Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)